POST Online Media Lite Edition



 

Pfizer Q3 adjusted earnings beat estimates

Christian Fernsby |

KEY POINTS
  • Excluding items, Pfizer Inc. reported adjusted earnings of $4.21 billion
  • This compares with $4.11 billion in last year's third quarter

Pfizer reported earnings for its third quarter that increased from last year.

Article continues below



Topics: PFIZER   

The company's bottom line came in at $7.68 billion, or $1.36 per share. This compares with $4.11 billion, or $0.69 per share, in last year's third quarter.

Excluding items, Pfizer Inc. reported adjusted earnings of $4.21 billion or $0.75 per share for the period.

Analysts had expected the company to earn $0.62 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 4.7% to $12.68 billion from $13.30 billion last year.


What to read next

Pfizer updates guidance, expects diluted EPS to be $1.29-$1.38
Pfizer Q4 net income up to $12.27 billion
Movado Q4 adjusted operating income increased 43.5%